The COLO-COHORT (Colorectal Cancer Cohort) study: Protocol for a multi-centre, observational research study and development of a consent-for-contact research platform.

Publication Year: 2022

DOI:
10.1111/codi.16160

PMCID:
PMC9796014

PMID:
35470953

Journal Information

Full Title: Colorectal Dis

Abbreviation: Colorectal Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST CJR has received grant funding from ARC Medical, Norgine, Medtronic, 3D Matrix Solutions and Olympus Medical. He was an expert witness for ARC Medical. LS is in receipt of project grants from 3D Matrix and Medtronic. The remaining authors declare no competing interests."

Evidence found in paper:

"Funding information"

Evidence found in paper:

"Study registration: The study has been registered with ISRCTN (ISRCTN: 17473023) and Clinical Trials.gov (number NCT04185779). COLO‐COHORT is adopted to the National Institute for Health Research Clinical Research Network portfolio. This study is funded by GUTS UK (Charity Registration No. 1137029, formerly known as Core) which administers an award by Parabola and by the Sir Bobby Robson Foundation."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025